ANTARES PHARMA, INC.·4

Jun 14, 6:23 PM ET

GUETH ANTON 4

4 · ANTARES PHARMA, INC. · Filed Jun 14, 2021

Insider Transaction Report

Form 4
Period: 2021-06-10
GUETH ANTON
Director
Transactions
  • Award

    Common Stock

    2021-06-10$4.42/sh+25,452$112,498567,577 total
  • Award

    Stock Option (right to buy)

    2021-06-10+48,54248,542 total
    Exercise: $4.42Exp: 2031-06-10Common Stock (48,542 underlying)
Footnotes (3)
  • [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest one year from the grant date. The reporting person has elected to defer the receipt of shares until separation of service as a Director.
  • [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
  • [F3]The options vest and become exercisable one year from the grant date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_992661

    POA DOCUMENT